NCT03641703 - A Long-Term Follow-Up Study of Haemophilia B Patients Who Have Undergone Gene Therapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 10, 2018

Primary Completion Date

May 24, 2023

Study Completion Date

May 24, 2023

Conditions

Hemophilia B

Interventions

BIOLOGICAL

FLT180a

FLT180a is a replication-incompetent adeno-associated viral vector. The vector is composed of a DNA vector genome encapsidated in an adeno-associated virus derived protein capsid. The expression cassette contains DNA encoding Factor IX.

Trial Locations (6)

CT13NG

The Haemophilia and Thrombosis Centre, Canterbury

S102JF

Sheffield Teaching Hospital, Sheffield

Unknown

Royal Free London NHS Foundation Tust, London

Oxford University Hospitals NHS Foundation Trust, Oxford

NE14LP

Newcastle Hemophilia Comprehensive Care Centre, Newcastle

SO166YD

Southampton Haemophilia Comprehensive Care Centre, Southampton